在阿片类药物使用障碍中保持治疗的比较研究:皮下注射与舌下布普伦诺芬
Charles Deng1,2, Enrique Oviedo1,3, Marc Fishman4,5
1MATClinics.
Addiction (Abingdon, England)
|June 5, 2025
概括
对于阿片类药物使用障碍 (OUD) 的患者,过渡到注射性布普伦诺芬的患者,治疗保留率低于分言布普伦诺芬的患者. 这表明注射配方可能会增加OUD治疗中脱离治疗的风险.
科学领域:
- 成 药物 药物 药物 药物
- 药理学 药理学是指药理学的学科.
背景情况:
- 阿片类药物使用障碍 (OUD) 治疗通常使用语言下布普伦诺芬和延长释放注射配方.
- 仅有有限的数据可以比较这些布普伦诺芬输送方法之间的患者保留率.
研究的目的:
- 为了比较OUD患者的治疗延续时间,这些患者从舌下布普伦诺芬过渡到注射布普伦诺芬,以及那些继续接受舌下布普伦诺芬的患者.
- 分析门诊成治疗环境中的保留差异.
主要方法:
- 观察性倾向得分匹配的队列研究.
- 包括从2019年6月到2024年2月接受布普伦诺芬治疗OUD的3609名患者.
- 主要结果:停课时间. 使用卡普兰-梅尔和考克斯比例危险模型进行分析.
主要成果:
- 538名向注射性布伦诺芬 (INJ) 转换的患者与538名仅用下舌 (SUB) 患者进行了匹配.
- 与SUB-only患者相比,INJ患者的治疗持续时间明显较低.
- 药物中断的中位时间为INJ的269天,仅SUB的389天 (P<0.001).
结论:
- 过渡到注射性布普伦诺芬与OUD患者中断的风险增加有关.
- 在这种门诊环境中,口下布普伦诺芬显示出更好的患者保留率.
相关概念视频
Opioid Analgesics: Synthetic and Semisynthetic Opioids
936
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
936
Analgesia and Pain Management
1.5K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.5K
Drug Accumulation During Multiple Dosing: Repetitive IV Injections
256
Calculating drug dosage and accumulation in multiple-dose regimens is crucial for achieving therapeutic efficacy while avoiding toxicity. This involves determining the plasma drug concentrations over time to optimize dosing schedules. The principle of superposition is fundamental in this process, allowing for the prediction of drug concentration in plasma following multiple doses based on single-dose data.The principle of superposition asserts that the plasma concentration-time curves from...
256
Drug Delivery: Miscellaneous Routes
716
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
716
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
179
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
179
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
233
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
233


